MRKT Call: An Unbothered S&P 500
RiskReversal Pod
00:00
XLV Is Down Like Nine Weeks in a Row and I Think It's a Value Trap
The XLV the ETF that tracks the large you know pharma companies and also UNH is in there too to be down like eight weeks in a row. The rotation obviously has been into some of these higher valuation high growth tech names NVIDIA stands out but there have been others as well in terms of being value traps.
Play episode from 22:26
Transcript
